45% Leap In Notified-Body Certificates Withdrawn From Device Firms
Executive Summary
2016 saw the largest single-year rise in the number of EU certificates that were withdrawn from device companies by members of the TEAM-NB notified body association. The specific causes of the withdrawals varied, but increased regulatory expectations in the EU are likely an important factor.
You may also be interested in...
More EU Notified Bodies Bite The Dust
The number of notified bodies operating under the EU's current medical device directives continue to decline, and that trend is expected to persist with the new regulations entering into force. Here's a look at country-by-country trends in notified bodies operating under the three current medtech EU directives.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.